Raymond James Financial Inc Ptc Therapeutics, Inc. Transaction History
Raymond James Financial Inc
- $258 Billion
- Q1 2025
A detailed history of Raymond James Financial Inc transactions in Ptc Therapeutics, Inc. stock. As of the latest transaction made, Raymond James Financial Inc holds 56,027 shares of PTCT stock, worth $2.68 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
56,027
Previous 48,728
14.98%
Holding current value
$2.68 Million
Previous $2.2 Million
29.83%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding PTCT
# of Institutions
283Shares Held
78.5MCall Options Held
223KPut Options Held
156K-
Vanguard Group Inc Valley Forge, PA8.61MShares$412 Million0.01% of portfolio
-
Black Rock Inc. New York, NY7.77MShares$372 Million0.01% of portfolio
-
Rtw Investments, LP New York, NY7.48MShares$358 Million6.25% of portfolio
-
Armistice Capital, LLC New York, NY5.43MShares$260 Million4.22% of portfolio
-
Wellington Management Group LLP Boston, MA5.42MShares$259 Million0.05% of portfolio
About PTC THERAPEUTICS, INC.
- Ticker PTCT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 71,541,000
- Market Cap $3.42B
- Description
- PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines to patients with rare disorders. Its portfolio pipeline includes commercial products and product candidates in various stages of development, including clinical, pre-clinical and research and discovery stages, focuses on...